Shenzhen Neptunus Interlong Bio-technique Company Limited Share Price
Equities
8329
CNE100000775
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.156 HKD | +1.30% | -1.27% | -4.88% |
Sales 2022 | 987M 136M 1.07B 10.91B | Sales 2023 | 1.06B 147M 1.15B 11.77B | Capitalization | 250M 34.52M 270M 2.77B |
---|---|---|---|---|---|
Net income 2022 | 54M 7.45M 58.34M 597M | Net income 2023 | 24M 3.31M 25.93M 265M | EV / Sales 2022 | - |
Net cash position 2022 | 257M 35.52M 278M 2.85B | Net cash position 2023 | 293M 40.37M 316M 3.23B | EV / Sales 2023 | -0.04 x |
P/E ratio 2022 |
4.69
x | P/E ratio 2023 |
10.4
x | Employees | 1,444 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.13% |
1 day | +1.30% | ||
1 week | -1.27% | ||
Current month | -1.27% | ||
1 month | -3.11% | ||
3 months | +2.63% | ||
6 months | -4.88% | ||
Current year | -4.88% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Zhang
CHM | Chairman | 52 | 31/05/11 |
Jian Bo Huang
BRD | Director/Board Member | 47 | 23/04/20 |
Wai Sum Fung
SEC | Corporate Secretary | 41 | 31/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Bo Huang
BRD | Director/Board Member | 47 | 23/04/20 |
Feng Zhang
CHM | Chairman | 52 | 31/05/11 |
Lin Yu
BRD | Director/Board Member | 66 | 31/01/05 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.156 | +1.30% | 80,000 |
25/04/24 | 0.154 | -0.65% | 130,000 |
24/04/24 | 0.155 | 0.00% | 330,000 |
23/04/24 | 0.155 | +2.65% | 70,000 |
22/04/24 | 0.151 | -4.43% | 10,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.88% | 33.44M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 8329 Stock